Evaluation of specific immune response in early P. aeruginosa infection in cystic fibrosis patients

Journal of Cystic Fibrosis

Volumn 13, Issue 1, 2014, Pages 116-117

  Dolce, Daniela ^a   Cariani, Lisa ^b   Campana, Silvia ^a   Ravenni, Novella ^a   Mergni, Gianfranco ^a   Biffi, Arianna ^b   Colombo, Carla ^b   Gagliardini, Rolando ^c   Cirilli, Natalia ^c   Manso, Ester ^c   Padoan, Rita ^d   Soncini, Elena ^d   Forte, Fabio Rocco ^e   D'Aprile, Angelica ^f   Ratclif, Luigi ^f   Amboni, Maura ^g   Casciaro, Rosaria ^h   Minicucci, Laura ^h   Borio, Tatiana ⁱ   Cosimi, Angelo ⁱ   Vieni, Giuseppe ^j   Zinnarello, Clara ^j   Fiscarelli, Ersilia ^k   Collura, Mirella ^l   Pensabene, Tiziana ^l   Braggion, Cesare ^a   Döring, Gerd ^m   Taccetti, Giovanni ^a   more..

^a UNIVERSITY OF FLORENCE   (Italy)

^b FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^c OSPEDALI RIUNITI   (Italy)

^d Pediatric Surgery Department   (Italy)

^e Ospedale Civile di Matera   (Italy)

^f Ospedale G Tatarella   (Italy)

^g BUFALINI HOSPITAL   (Italy)

^h G GASLINI INSTITUTE   (Italy)

ⁱ Ospedale di Gubbio Gualdo Tadino   (Italy)

^j UNIVERSITY OF MESSINA   (Italy)

^k BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

^l Ospedale dei Bambini G Di Cristina   (Italy)

^m UNIVERSITY OF TÜBINGEN   (Germany)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PROTEINASE; BACTERIUM ANTIBODY; CIPROFLOXACIN; COLISTIN; ELASTASE; PSEUDOMONAS EXOTOXIN; TOBRAMYCIN;

ANTIBIOTIC THERAPY; ANTIBODY TITER; BACTERIAL CLEARANCE; CLINICAL TRIAL (TOPIC); CYSTIC FIBROSIS; DRUG EFFICACY; ENZYME LINKED IMMUNOSORBENT ASSAY; FOLLOW UP; HUMAN; IMMUNE RESPONSE; LETTER; PATHOGENESIS; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTION; SEROLOGY;

ANTI-BACTERIAL AGENTS; CHILD; CHILD, PRESCHOOL; CYSTIC FIBROSIS; HUMANS; INFANT; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; RISK FACTORS; TREATMENT OUTCOME;

EID: 84890435848     PISSN: 15691993     EISSN: 18735010     Source Type: Journal    
DOI: 10.1016/j.jcf.2013.08.003     Document Type: Letter

References (4)

1. Anstead M., Heltshe S.L., Khan U., Barbieri J.T., Langkamp M., Döring G., et al. Pseudomonas aeruginosa serology and risk for re-isolation in the EPIC trial. J Cyst Fibros 2013, 12:147-153.
2. Taccetti G., Bianchini E., Cariani L., Buzzetti R., Costantini D., Trevisan F., et al. Early antibiotic treatment for Pseudomonas aeruginosa eradication in patients with cystic fibrosis: a randomised multicentre study comparing two different protocols. Thorax 2012, 67:853-859.
3. Ratjen F., Walter H., Haug M., Meisner C., Grasemann H., Doring G. Diagnostic value of serum antibodies in early pa infection in cystic fibrosis patients. Pediatr Pulmonol 2007, 42:249-255.
4. The UK Cystic Fibrosis Trust Infection Control Group Pseudomonas aeruginosa infection in people with cystic fibrosis. Suggestions for prevention and infection control 2004, Cystic Fibrosis Trust, Bromley UK. 2nd ed.